93 related articles for article (PubMed ID: 28880488)
1. Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.
Toyoda H; Hiraoka A; Tada T; Michitaka K; Takaguchi K; Tsuji K; Itobayashi E; Takizawa D; Hirooka M; Koizumi Y; Ochi H; Joko K; Kisaka Y; Shimizu Y; Tajiri K; Tani J; Taniguchi T; Toshimori A; Fujioka S; Kumada T
Ther Apher Dial; 2017 Oct; 21(5):465-472. PubMed ID: 28880488
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?
Lee YH; Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI
J Gastroenterol Hepatol; 2013 Feb; 28(2):348-56. PubMed ID: 23190248
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.
Su CW; Lei HJ; Chau GY; Hung HH; Wu JC; Hsia CY; Lui WY; Su YH; Wu CW; Lee SD
Arch Surg; 2012 Feb; 147(2):137-44. PubMed ID: 22006855
[TBL] [Abstract][Full Text] [Related]
4. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
[TBL] [Abstract][Full Text] [Related]
5. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
8. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
9. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.
Bossen L; Grønbaek H; Lykke Eriksen P; Jepsen P
Liver Int; 2017 Jul; 37(7):1042-1046. PubMed ID: 28317318
[TBL] [Abstract][Full Text] [Related]
10. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
J Gastroenterol Hepatol; 2012 Apr; 27(4):690-9. PubMed ID: 22436058
[TBL] [Abstract][Full Text] [Related]
11. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
[TBL] [Abstract][Full Text] [Related]
14. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
15. Characteristic differences of hepatocellular carcinoma in Japan, with special reference to liver weight at autopsy.
Horie Y; Maeda N; Kawasaki H; Suyama A
Hepatogastroenterology; 1997; 44(17):1407-12. PubMed ID: 9356864
[TBL] [Abstract][Full Text] [Related]
16. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
Takahara T; Wakabayashi G; Beppu T; Aihara A; Hasegawa K; Gotohda N; Hatano E; Tanahashi Y; Mizuguchi T; Kamiyama T; Ikeda T; Tanaka S; Taniai N; Baba H; Tanabe M; Kokudo N; Konishi M; Uemoto S; Sugioka A; Hirata K; Taketomi A; Maehara Y; Kubo S; Uchida E; Miyata H; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):721-7. PubMed ID: 26096910
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.
Hong YF; Chen ZH; Ma XK; Li X; Wu DH; Chen J; Dong M; Wei L; Wang TT; Ruan DY; Lin ZX; Wen JY; Lin Q; Jia CC; Wu XY
Tumour Biol; 2016 Apr; 37(4):5265-73. PubMed ID: 26561464
[TBL] [Abstract][Full Text] [Related]
18. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan.
Toyoda H; Hiraoka A; Olivares J; Al-Jarrah T; Devlin P; Kaneoka Y; Maeda A; Yopp AC; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2379-2388.e6. PubMed ID: 33295281
[TBL] [Abstract][Full Text] [Related]
20. Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
Urakawa H; Kora SI; Mitsufuji T; Osame A; Higahsihara H; Yoshimitsu K
Acta Radiol; 2016 Dec; 57(12):1445-1452. PubMed ID: 26861204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]